Systemic Lupus Erythematosus
📧 Sign up to get email alerts when something new happens for Systemic Lupus Erythematosus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune Diseases [Phase 1]
Phase 1 trial evaluating autologous CD19/BCMA dual-target CAR-T therapy for relapsed/refractory autoimmune diseases; currently recruiting at…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: KN5501 Cell Injection for Refractory SLE(CLEAR) [Phase 1]
Phase 1 trial update for KN5501 cell injection in refractory systemic lupus erythematosus (SLE) by Ruitherapeutics Co., Ltd. The study is cu…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases [Phase 1]
A Phase 1 clinical trial evaluating QT-019C, a CD19 and BCMA-targeted CAR T-cell therapy, for relapse/refractory autoimmune diseases; recrui…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: It is an Observational Study That Compare Prognosis of Typical and Atypical Systemic Lupus Erythematosus Presentation
An observational study comparing prognosis between typical and atypical presentations of systemic lupus erythematosus. The study is not yet …
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Exploring and Measuring the Impact of Steroids in Children and Young People
A recruiting clinical trial investigating how steroids affect health outcomes in children and young people with rheumatic diseases, includin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: HLA Antibodies in Systemic Lupus Erythematosus
A clinical trial is currently recruiting to study HLA antibodies in patients with Systemic Lupus Erythematosus at Centre Hospitalier Univers…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: A Clinical Study Exploring the Safety, Efficacy and Cell Metabolic Dynamics of Universal CD19 / 20 Car-t Cell Injection in Moderate to Severe Refractory Systemic Lupus Erythematosus [EARLY_Phase 1]
Early-phase clinical study evaluating universal CD19/CD20 CAR-T cell therapy for safety and potential efficacy in moderate to severe refract…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Study of Ultra-Fast CD19 CAR-T Therapy for Refractory SLE [Phase 1]
Phase 1 clinical trial evaluating Ultra-Fast CD19 CAR-T cell therapy for refractory systemic lupus erythematosus is currently recruiting. Th…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases [Phase 1]
Century Therapeutics’ CNTY-101 is being evaluated in a Phase 1 study for refractory B cell–mediated autoimmune diseases, with the trial curr…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Creating Health Course Study for People With Rheumatological Conditions [NA]
A new health course study for people with rheumatological conditions is currently recruiting, spanning rheumatoid arthritis, Sjögren's syndr…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Duke Lupus Registry
This ClinicalTrials.gov entry reports that the Duke Lupus Registry study is currently recruiting participants for research on systemic lupus…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Maternal Autoimmune Disease Research Alliance (MADRA) Registry
Duke University’s MADRA pregnancy autoimmune disease registry is actively recruiting to study autoimmune conditions during pregnancy, includ…
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: ACE1831 in Adult Subjects With Relapsed/Refractory Systemic Lupus Erythematosus （SLE） [NA]
ACE1831 is being studied in adults with relapsed/refractory systemic lupus erythematosus; this Tongji Hospital-sponsored trial is not yet re…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Pregnancies Before the Diagnosis of Systemic Lupus Erythematosus
A University of Algiers-sponsored clinical trial investigates pregnancies occurring before the diagnosis of systemic lupus erythematosus and…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases
A clinical trial update indicates a study assessing the effects of phytocannabinoids on immune response and autophagy in chronic immune-medi…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Helping Lupus Patients Manage Fibromyalgia Symptoms Through Emotional Awareness and Expression Therapy (EAET) [NA]
A University of Utah-led trial is evaluating whether Emotional Awareness and Expression Therapy (EAET) can help alleviate fibromyalgia sympt…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases [NA]
This clinical trial is recruiting to evaluate anti-CD19 IL-10/IL-15 CAR-NK cells for refractory/relapsed autoimmune diseases. Conditions inc…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Safety of the Herpes Zoster Subunit Vaccine in Lupus [Phase 4]
A Phase 4 clinical trial is evaluating the safety of a herpes zoster subunit vaccine in patients with Systemic Lupus Erythematosus and is cu…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Complete Cognitive Intervention for cSLE [NA]
A clinical trial update for a complete cognitive intervention in childhood-onset systemic lupus erythematosus (cSLE), with the study current…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: A Study Evaluating the Effects of GLPG3667 Administered as Oral Treatment in Adult Participants With Active Systemic Lupus Erythematosus [Phase 2]
A Phase 2 clinical trial evaluating GLPG3667 in adults with active systemic lupus erythematosus is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: The Value of Interleukin-1β and Interleukin-33 Genetic Expression in the Pathogenesis and Differentiation of Primary ITP and SLE-Related Thrombocytopenia
This clinical trial update outlines research into the role of genetic expression of interleukin-1β and interleukin-33 in the pathogenesis of…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Balancing Lupus Experiences With Stress Strategies [Phase 1, Phase 2]
This entry reports on a Phase 1/2 clinical trial exploring stress-management strategies for systemic lupus erythematosus; the study has comp…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Biocollection of Rare Pediatric-onset of Autoimmune and Autoinflammatory Diseases [NA]
A clinical trial protocol for a biocollection studying rare pediatric-onset autoimmune and autoinflammatory diseases, including systemic lup…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Clinical Trial of CD19 Targeted CAR-T Cell in Refractory Adult SLE [Phase 1]
Phase 1 clinical trial evaluating a CD19-targeted CAR-T cell therapy in adults with refractory systemic lupus erythematosus is currently rec…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: A Study of CD19 UCAR-T Cells in Subjects With Autoimmune Diseases [NA]
A clinical trial update evaluating CD19 UCAR-T cell therapy in autoimmune diseases; the study is not yet recruiting.